Matches in SemOpenAlex for { <https://semopenalex.org/work/W3172941013> ?p ?o ?g. }
- W3172941013 endingPage "1997" @default.
- W3172941013 startingPage "1997" @default.
- W3172941013 abstract "In this case-control, cross-sectional, observational study, we evaluated circulating trimethylamine n-oxide (TMAO) levels, a gut-derived metabolite associated with inflammation and cardiometabolic risk, in patients with hidradenitis suppurativa (HS), a highly disabling inflammatory skin disease associated with an elevated prevalence of comorbidities, especially cardiovascular and metabolic diseases. In this study, we enrolled 35 naive-treatment patients with HS and 35 controls, matched for sex, age, and body mass index (BMI). HS Sartorius score was 49.0 (33.0–75.0), while according to the Harley system 12 and 23 patients presented grade 1 and grade 2 severity, respectively. HS patients had a lower adherence to the Mediterranean diet (MD) (p = 0.002), lower phase angle (PhA) (p < 0.001), and higher circulating TMAO levels (p < 0.001) than the control group. HS patients with grade 2 rather than grade 1 of Harley grade severity showed a higher BMI (p = 0.007), waist circumference (p = 0.016), total energy intake (p = 0.005), and lower PhA (p < 0.001) and adherence to the MD (p = 0.003). Of interest, patients with Hurley grade 2 of severity exhibited higher circulating TMAO levels (p < 0.001) compared to grade 1. Circulating TMAO levels showed a positive correlation with HS Sartorius score even after adjustment for confounding covariates, including BMI, waist circumference, adherence to the MD, total energy intake, and PhA (r = 0.570, p = 0.001). Using a linear regression model, circulating TMAO levels and PhA were the main predictors of the clinical severity of HS." @default.
- W3172941013 created "2021-06-22" @default.
- W3172941013 creator A5003626319 @default.
- W3172941013 creator A5015141404 @default.
- W3172941013 creator A5026402548 @default.
- W3172941013 creator A5030017563 @default.
- W3172941013 creator A5034262621 @default.
- W3172941013 creator A5058627211 @default.
- W3172941013 creator A5064439351 @default.
- W3172941013 creator A5066892710 @default.
- W3172941013 creator A5070034601 @default.
- W3172941013 creator A5074421301 @default.
- W3172941013 date "2021-06-10" @default.
- W3172941013 modified "2023-09-24" @default.
- W3172941013 title "Association of Trimethylamine N-Oxide (TMAO) with the Clinical Severity of Hidradenitis Suppurativa (Acne Inversa)" @default.
- W3172941013 cites W1721642365 @default.
- W3172941013 cites W176759912 @default.
- W3172941013 cites W1979806455 @default.
- W3172941013 cites W1982341124 @default.
- W3172941013 cites W1995627534 @default.
- W3172941013 cites W1996601924 @default.
- W3172941013 cites W2016019060 @default.
- W3172941013 cites W2019250224 @default.
- W3172941013 cites W2027907732 @default.
- W3172941013 cites W2032597601 @default.
- W3172941013 cites W2032959495 @default.
- W3172941013 cites W2039622411 @default.
- W3172941013 cites W2044590762 @default.
- W3172941013 cites W2048816147 @default.
- W3172941013 cites W2056088037 @default.
- W3172941013 cites W2138012664 @default.
- W3172941013 cites W2141345199 @default.
- W3172941013 cites W2199096407 @default.
- W3172941013 cites W2205710834 @default.
- W3172941013 cites W2297096197 @default.
- W3172941013 cites W2372648738 @default.
- W3172941013 cites W2414025904 @default.
- W3172941013 cites W2499227793 @default.
- W3172941013 cites W2512999439 @default.
- W3172941013 cites W2535219518 @default.
- W3172941013 cites W2574310714 @default.
- W3172941013 cites W2588665151 @default.
- W3172941013 cites W2606470589 @default.
- W3172941013 cites W2625202156 @default.
- W3172941013 cites W2742647851 @default.
- W3172941013 cites W2747751462 @default.
- W3172941013 cites W2750649253 @default.
- W3172941013 cites W2794989499 @default.
- W3172941013 cites W2795933951 @default.
- W3172941013 cites W2801185785 @default.
- W3172941013 cites W2890387912 @default.
- W3172941013 cites W2892281895 @default.
- W3172941013 cites W2897958047 @default.
- W3172941013 cites W2901701050 @default.
- W3172941013 cites W2902174421 @default.
- W3172941013 cites W2904239670 @default.
- W3172941013 cites W2907893309 @default.
- W3172941013 cites W2911214832 @default.
- W3172941013 cites W2952635072 @default.
- W3172941013 cites W2954705097 @default.
- W3172941013 cites W2965326129 @default.
- W3172941013 cites W2970426636 @default.
- W3172941013 cites W2970456585 @default.
- W3172941013 cites W2973181305 @default.
- W3172941013 cites W2973552995 @default.
- W3172941013 cites W2991551461 @default.
- W3172941013 cites W2995238755 @default.
- W3172941013 cites W3000347847 @default.
- W3172941013 cites W3004700781 @default.
- W3172941013 cites W3008592425 @default.
- W3172941013 cites W3013024119 @default.
- W3172941013 cites W3021476457 @default.
- W3172941013 cites W3022974816 @default.
- W3172941013 cites W3024169803 @default.
- W3172941013 cites W3025774350 @default.
- W3172941013 cites W3028844636 @default.
- W3172941013 cites W3040293020 @default.
- W3172941013 cites W3041675808 @default.
- W3172941013 cites W3047297438 @default.
- W3172941013 cites W3048761074 @default.
- W3172941013 cites W3049306791 @default.
- W3172941013 cites W3081828681 @default.
- W3172941013 cites W3083306534 @default.
- W3172941013 cites W3088269767 @default.
- W3172941013 cites W3092268290 @default.
- W3172941013 cites W3106799097 @default.
- W3172941013 cites W3120051316 @default.
- W3172941013 cites W3124488291 @default.
- W3172941013 cites W3127804125 @default.
- W3172941013 cites W3150359717 @default.
- W3172941013 cites W3158182752 @default.
- W3172941013 cites W3159272007 @default.
- W3172941013 doi "https://doi.org/10.3390/nu13061997" @default.
- W3172941013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8226830" @default.
- W3172941013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34200594" @default.
- W3172941013 hasPublicationYear "2021" @default.
- W3172941013 type Work @default.
- W3172941013 sameAs 3172941013 @default.